Literature DB >> 19672965

Postsurgery serum thyroglobulin disappearance kinetic in patients with differentiated thyroid carcinoma.

Luca Giovanella1, Luca Ceriani, Marco Maffioli.   

Abstract

BACKGROUND: Knowing the postsurgery thyroglobulin (Tg) kinetic would enable its rationale for use in patients with differentiated thyroid cancer (DTC). Heterogeneous results were previously reported, then we aimed to evaluate the postsurgery Tg kinetic in a large group of patients with DTC.
METHODS: Enrolled were 96 patients with DTC. Serum Tg was measured first at 5 minutes, then at 24, 48, 72, 96, and 120 hours after thyroidectomy. The Tg half-life (Tg[t(1/2)]) was estimated in a 1-compartment model. A simplified 2-point formula (24 and 120 hours) was also used.
RESULTS: The mean Tg(t(1/2)) was 28.53 to 30.22 hours in 1-compartment model and 27.39 hours when estimated by a simplified formula. A strong inter-methods relationship was found (p < .001).
CONCLUSIONS: A reliable Tg(t(1/2)) estimation could be obtained by a simplified formula requiring only 2 postsurgery Tg measurements (24 and 120 hours, respectively).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19672965     DOI: 10.1002/hed.21214

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  9 in total

Review 1.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

Review 2.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

3.  Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine.

Authors:  Denise P Momesso; Fernanda Vaisman; Samantha P Yang; Daniel A Bulzico; Rossana Corbo; Mario Vaisman; R Michael Tuttle
Journal:  J Clin Endocrinol Metab       Date:  2016-03-29       Impact factor: 5.958

4.  BEHAVIOUR OF EARLY THYROGLOBULIN AFTER TOTAL THYROIDECTOMY FOR DIFFERENTIATED THYROID CANCER.

Authors:  D Pérez; M Marulanda; A Sanabria
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

5.  Serum Thyroglobulin: Preoperative Levels and Factors Affecting Postoperative Optimal Timing following Total Thyroidectomy.

Authors:  Anery Patel; Valerie Shostrom; Kelly Treude; William Lydiatt; Russell Smith; Whitney Goldner
Journal:  Int J Endocrinol       Date:  2019-02-20       Impact factor: 3.257

6.  The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer.

Authors:  Hee Kyung Kim; Jee Hee Yoon; Jin Seong Cho; Seong Young Kwon; Su Woong Yoo; Ho-Cheol Kang
Journal:  Korean J Intern Med       Date:  2019-07-29       Impact factor: 2.884

7.  Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy.

Authors:  Zhichao Xing; Yuxuan Qiu; Zhe Li; Lingyun Zhang; Yuan Fei; Jingqiang Zhu; Anping Su
Journal:  BMC Surg       Date:  2021-01-22       Impact factor: 2.102

8.  Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients' Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial.

Authors:  Anwar A Jammah; Afshan Masood; Layan A Akkielah; Shaimaa Alhaddad; Maath A Alhaddad; Mariam Alharbi; Abdullah Alguwaihes; Saad Alzahrani
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-24       Impact factor: 5.555

Review 9.  Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper.

Authors:  Luca Giovanella; Penelope M Clark; Luca Chiovato; Leonidas Duntas; Rossella Elisei; Ulla Feldt-Rasmussen; Laurence Leenhardt; Markus Luster; Camilla Schalin-Jäntti; Matthias Schott; Ettore Seregni; Herald Rimmele; Jan Smit; Frederik A Verburg
Journal:  Eur J Endocrinol       Date:  2014-04-17       Impact factor: 6.664

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.